Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous-cell carcinoma

International Journal of Cancer

Volumn 82, Issue 3, 1999, Pages 377-384

  Thomas, Giovana R ^a   Chen, Zhong ^a   Oechli, Malgorzata N ^b   Hendler, Fred J ^b   Van Waes, Carter ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b University of Louisville School of Medicine   (United States)

^c NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; B7 ANTIGEN; CD86 ANTIGEN; CYTOKERATIN; INTEGRIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CARCINOGENICITY; CONTROLLED STUDY; IMMUNOGENICITY; MALE; MOUSE; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; ANIMALS, CONGENIC; ANTIGENS, CD80; CARCINOMA, SQUAMOUS CELL; CELL LINE, TRANSFORMED; CLONE CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOCOMPETENCE; LYMPHOCYTE COUNT; MALE; MICE; MICE, INBRED BALB C; MICE, SCID; MOUTH NEOPLASMS; PHENOTYPE; QUINOLONES; SEVERE COMBINED IMMUNODEFICIENCY; TUMOR MARKERS, BIOLOGICAL;

EID: 0033046904     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990730)82:3<377::AID-IJC11>3.0.CO;2-9     Document Type: Article

References (22)

1. BAIN, C., MERROUCHE, Y., PUISIEUX, I., DUC, A., COLOMBO, M.P. and FAVROT, M., B7-1 gene transduction of human renal cell carcinoma cell lines restores the proliferative response and cytotoxic function of allogeneic T cells. Int. J. Cancer, 67, 769-776 (1996).
2. CHAMBERS, C.A. and ALLISON, J.P., Co-stimulation in T cell responses. Curr. Opin. Immunol., 9, 396-404 (1997).
3. CHEN, L., MCGOWAN, P., ASHE, S., JOHNSTON, J., LI, Y., HELLSTROM, I. and HELLSTROM, K.E., Tumor immunogenicity determines the effect of B7 co-stimulation on T-cell-mediated tumor immunity. J. exp. Med., 179, 523-532 (1994).
4. CHEN, Z., SMITH, C.W., KIEL, D. and VAN WAES, C., Metastatic variants derived following in vivo tumor progression of an in vitro transformed squamous cell carcinoma line acquire a differential growth advantage requiring tumor-host interaction. Clin. exp. Metastasis, 15, 527-537 (1997).
5. CRANE, J.T., LUKA, T., DEGAY, L., RICE, S.Q.T., STONE, A., SCULLY, C. and PRINE, S.S., Transformation of oral keratinocytes in vitro by 4-nitroquinolone-N-oxide. Carcinogenesis, 9, 2251-2256 (1998).
6. DESSUREAULT, S. and GALLINGER, S., Allogeneic lymphocyte responses to B7-1 expressing human cancer cell lines. J. Surg. Res., 64, 42-48 (1996).
7. HARDING, F.A., MCARTHUR, J.G., GROSS, J.A., RAULET, D.H. and ALLISON, J.P., CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature (Lond.), 356, 607-609 (1992).
8. HAWKINS, B.L., HENIFORD, B.W., ACKERMAN, D.M., LEONBERGER, M., MARTINEZ, S.A. and HENDLER, F.J., 4NQO carcinogenesis: a mouse model of oral cavity squamous cell carcinoma. Head Neck, 16, 424-432 (1994).
9. KUCHROO, V.K., DAS, M.P., BROWN, J.A., RANGER, A.M., ZAMVIL, S.S., SOBEL, R.A., WEINER, H.L., NABAVI, N. and GLIMCHER, L.H., B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell, 80, 707-718 (1995).
10. LENSCHOW, D.J., WALUNAS, T.L. and BLUESTONE, J.A., CD28/B7 system of T cell costimulation. Ann. Rev. Immunol., 14, 233-258 (1996).
11. NASIR, A., FERBEL, B. and GASPARI, A.A., Human keratinocytes regulate their expression of B7/BB-1 antigen by a unique, calcium-dependent mechanism. J. invest. Dermatol., 104, 763-767 (1995).
12. NATIONAL INSTITUTES OF HEALTH, Guidelines for care and use of laboratory animals, NIH Publication 86-23, NIH, Bethesda.
13. OTTEN, H.N., VERVERS, C. and DE GAST, G.C., Primary T-cell responses induced by B7-transfected keratinocytes (letter). Immunol. Today, 17, 292 (1996).
14. SCHWARTZ, R.H., Models of T cell anergy: is there a common molecular mechanism? J. exp. Med., 184, 1-8 (1996).
15. SPERLING, A.I. and BLUESTONE, J.A., The complexities of T-cell co-stimulation: CD28 and beyond. Immunol. Rev., 153, 155-182 (1996).
16. TATSUMI, T., TAKEHARA, T., KATAYAMA, K., MOCHIZUKI, K., YAMAMOTO, M., KANTO, T., SASAKI, Y., KASAHARA, A. and HAYASHI, N., Expression of co-stimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma. Hepatology, 25, 1108-1114 (1997).
17. VAN WAES, C., URBAN, J.L., ROTHSTEIN, J.L., WARD, P.L. and SCHREIBER, H., Highly malignant tumor variants retain tumor-specific antigens recognized by T-helper cells. J. exp. Med., 164, 1547-1565 (1986).
18. WANG, Y., ZHU, L., MCHUGH, R., GRAHAM, S.D., HILLYER, C.D., DILLEHAY, D., SELL, K.W. and SELVARAJ, P., Induction of autologous tumor-specific cytotoxic T lymphocyte activity against a human renal carcinoma cell line by B7-1 (CD80) co-stimulation. J. Immunother., 19, 1-8 (1996).
19. WILLIAMS, I.R., ORT, R.J., DALEY, D., MANNING, L., KARAOLI, T., BARNHILL, R.L. and KUPPER, T.S., Constitutive expression of B7-1 (CD80) on mouse keratinocytes does not prevent development of chemically induced skin papillomas and carcinomas. J. Immunol., 156, 3382-3388 (1996).
20. YEH, K., CHEN, Z., NASIR, A., OHSUGA, Y., TAKASHIMA, A., LORD, E.M. and GASPARI, A.A., Expression of B7-1 by Pam 212 squamous cell carcinoma enhances tumor cell interactions with dendritic epidermal T cells but does not affect in vivo tumor growth. J. invest. Dermatol., 109, 728-733 (1997).
21. YEH, K., PULASKI, B.A., WOODS, M.L., MCADAM, A.J., GASPARI, A.A., FRELINGER, J.G. and LORD, E.M., B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma. Cell. Immunol., 165, 217-224 (1995).
22. YUAN, B., HENIFORD, B.W., ACKERMAN, D.M., HAWKINS, B.L. and HENDLER, F.J., Harvey ras (H-ras) point mutations are induced by 4-nitroquinolone-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure. Cancer Res., 54, 5310-5317 (1994).